Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Formulation and Evaluation of Multiparticulate Drug Delivery System of Valsartan


Affiliations
1 Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka-576104, India
     

   Subscribe/Renew Journal


The objective of the present study was to prepare valsartan pellets and to coat with pH-responsive polymers for chronomodulated delivery. The pellets containing valsartan, Avicel and lactose were prepared by extruder spheronizer using different binders HPMC E-5 and PVP K-30. The optimized pellets were coated with different weight ratios of pH-responsive polymers Eudragit® S100 or RS. The pellets were evaluated for physical properties namely, surface appearance, size analysis, content uniformity, micromeritic properties, friability, infrared spectroscopy, differential scanning calorimetry, scanning electron microscopy, Feret diameter, aspect ratio, stability study and in vitro release studies. Based on in vitro release studies and SEM analysis, pellets containing 2.5% PVP K-30 were found to be optimized for coating. The drug was compatible when mixed with excipients, which was confirmed by IR spectroscopy and differential scanning calorimetry. Pellets showed good micromeritic properties. Further, in vitro release study of coated pellets revealed optimum lag-time (6±0.25 h) before drug release and Eudragit® S100 with 25% weight gain was optimized. There was no significant change in the drug content and release profile of the pellets stored under accelerated conditions. Thus the multiparticulate delivery system of valsartan found to be suitable as potential chronomodulated drug delivery system to treat early morning surge in hypertensive patients.

Keywords

Valsartan, Multiparticulate Drug Delivery System, Pellets, Chronomodulated Drug Delivery, Eudragit®
Subscription Login to verify subscription
User
Notifications
Font Size


  • Mohamad A and Dashevsky A. Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat ECD. International Journal of Pharmaceutics. 318; 2006: 124-131.

  • Madat DV et al. Development of venlafaxine hydrochloride controlled release pellets prepared employing he blend of ethyl cellulose and polyethylene oxide. Research Journal of Pharmacy and Technology. 5; 2012: 1289-1292.

  • Rakesh N et al. Drug Multiparticulate Production and Coating Technology – A Review. Research Journal of Pharmacy and Technology. 4; 2011: 1-18.

  • Sapkal SR et al. Pellets as Controlled Release Drug Delivery System: A Review, Research Journal of Pharmaceutical Dosage Form and Technology. 1; 2009: 179-183.

  • Roy P and Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. Journal of Controlled Release.134; 2009: 74-80.

  • Garekani HA et al. Preparation and characterization and release properties of Eudragit® RS based ibuprofen pellets prepared by extrusion spheronization: effect of binder type and concentration. Drug Development and Industrial Pharmacy. Early Online; 2012: 1–9.

  • Chourasia MK and Jain SK. Polysaccharides based colon-specific drug delivery. In: Progress in Controlled and Novel Drug Delivery System, Edited by Jain NK. CBS Publishers & Distributors, New Delhi, 2005; pp. 405-432.

  • Vasanth Kumar K et al. Phase -1 clinical trials on formulation and evaluation of colon specific methylprednisolone matrix enteric coated tablets. Research Journal of Pharmacy and Technology. 5; 2012: 905-911.

  • Patil PB et al. Development and Evaluation of Mesalamine Tablet Formulation for Colon Delivery. Research Journal of Pharmacy and Technology. 4; 2011: 1751-1756.

  • Jessy Shaji and Amol Shinde. Formulation and Evaluation of Floating Pulsatile Microspheres of Aceclofenac for Rheumatoid Arthritis. Research Journal of Pharmacy and Technology. 4; 2011: 1877-1881.

  • Kendall RA and Basit AW. The role of polymers in solid oral dosage forms. In: Polymers in Drug Delivery, Edited by Uchegbu IF, Schatzlein AG. CRC Press, Taylor and Francis group, 2006; pp. 35-48.

  • Sureshkumar R et al. Formulation and evaluation of pectinhydroxypropyl methylcellulose coated curcumin pellets for colon delivery. Asian Journal of Pharmaceutics. 3; 2009: 138-142.

  • Akhgari A, Sadeghi F and Garekani HA. Combination of timedependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets International Journal of Pharmaceutics. 320; 2006: 137-142.

  • Shivakumar HN, Sarasija S and Desai BG. Design and evaluation of pH sensitive multiparticulate systems for chronotherapeutic delivery of diltiazem hydrochloride. Indian Journal of Pharmaceutical Sciences. 68; 2006: 781-787.

  • Nayak UY et al. Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system. Journal of Controlled Release. 136; 2009: 125-131.

  • Liebermann HA, Lachman L and Schwartz JB. Pharmaceutical Dosage Forms: Tablets. Vol. 2, Marcel Dekker, New York, 1990; pp. 201-243.

  • Wells JI and Aulton ME. Pharmaceutical preformulation. In: Aultons Pharmaceutics—the Design and Manufacture of Medicines, Edited by Aulton ME. Elsevier, Churchill Livingstone, 2007; 3rd ed: pp. 337–360.

  • Shavi GV et al. Multiparticulate drug delivery system of aceclofenac: Development and in vitro studies. Drug Development and Industrial Pharmacy. 35; 2009: 252–258.

  • O’Connor RE and Schwartz JB. Powders. In: Gennaro, A.R. (Ed.) Remington, The Science and Practice of Pharmacy, Vol. 1, Lippincott Williams and Wilkins, USA, 2000; pp. 681-699.

  • Rodriguez EC et al. Micromeritic and packing properties of diclofenac pellets and effects of some formulation variables. Drug Development and Industrial Pharmacy. 27; 2001: 847- 855.

  • Heng PW, Liew CV and Gu L. Influence of teardrop studs on rotating frictional base plate on spheroid quality in rotary spheronization. International Journal of Pharmaceutics. 241; 2002: 173-184.

  • Bornhoft M, Thommes M and Kleinebudde P. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation. European Journal of Pharmaceutics and Biopharmaceutics. 59; 2005: 127–131.

  • McConnell EL, Fadda HM and Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. International Journal of Pharmaceutics. 364; 2008: 213-226.

  • McConnell EL, Short MD and Basit AW. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. Journal of Controlled Release. 130; 2008: 154-160.


Abstract Views: 2144

PDF Views: 0




  • Formulation and Evaluation of Multiparticulate Drug Delivery System of Valsartan

Abstract Views: 2144  |  PDF Views: 0

Authors

Usha Yogendra Nayak
Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka-576104, India
Gopal V. Shavi
Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka-576104, India
Srinivas Mutalik
Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka-576104, India
Nayanabhirama Udupa
Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka-576104, India

Abstract


The objective of the present study was to prepare valsartan pellets and to coat with pH-responsive polymers for chronomodulated delivery. The pellets containing valsartan, Avicel and lactose were prepared by extruder spheronizer using different binders HPMC E-5 and PVP K-30. The optimized pellets were coated with different weight ratios of pH-responsive polymers Eudragit® S100 or RS. The pellets were evaluated for physical properties namely, surface appearance, size analysis, content uniformity, micromeritic properties, friability, infrared spectroscopy, differential scanning calorimetry, scanning electron microscopy, Feret diameter, aspect ratio, stability study and in vitro release studies. Based on in vitro release studies and SEM analysis, pellets containing 2.5% PVP K-30 were found to be optimized for coating. The drug was compatible when mixed with excipients, which was confirmed by IR spectroscopy and differential scanning calorimetry. Pellets showed good micromeritic properties. Further, in vitro release study of coated pellets revealed optimum lag-time (6±0.25 h) before drug release and Eudragit® S100 with 25% weight gain was optimized. There was no significant change in the drug content and release profile of the pellets stored under accelerated conditions. Thus the multiparticulate delivery system of valsartan found to be suitable as potential chronomodulated drug delivery system to treat early morning surge in hypertensive patients.

Keywords


Valsartan, Multiparticulate Drug Delivery System, Pellets, Chronomodulated Drug Delivery, Eudragit®

References